Ingber D. Fujita T. Kishimoto S, et al: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth Nature 348:555-557. 1990
Kusaka M. Sudo K. Fujita T. et al: Potent anti angiogenic action of AGM-1470: comparisot to the fumagillin parent. Biochem Biophys Re: Commun 174:1070-1076, 1991
Antoine N, Greimers R. De Roanne C, et al AGM-1470, a potent angiogenests inhibitor body formation in vitro by CD40 ligand and IL-2. J Immunol 150:3141-3147, 1993
Antoine N, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle. Cancer Res 54:20732076. 1994
Schoof DD, Obando JA, Cusack JC, Jr, et al: The influence of angiogenesis inhibitor AGM-1470 on immune system status and tumor growth in vitro. Int J Cancer 55:630635. 1993
Berger AE, Dortch KA, Staite ND. et al: Modulation of T lymphocyte function by the angiogenesis inhibitor AGM-1470. Agents Actions 39:C86-C88, 1993
Grabstein KH, Maliszewski CR, Shanebeck K, et al: The regulation of T cell-dependent anti 150: 3141-3147, 1993
